Cancer Misdiagnosis and Delayed Diagnosis Lawsuits

The Recurring Breach Patterns

Cancer misdiagnosis cases tend to fall into one of a small number of recurring breach patterns:

• False-negative imaging. A screening or diagnostic study showed the lesion that was eventually diagnosed as cancer. The radiologist read the study as benign or normal. Plaintiff's radiology expert re-reads the original films and identifies the lesion. The case becomes a standard-of-care dispute on radiology interpretation.
• False-negative pathology. A biopsy showed cancer or pre-cancerous changes that the pathologist read as benign. The slides become evidence. Plaintiff's pathology expert reviews the original slides and identifies the missed malignancy.
• Alarm symptom attributed to a benign cause. Hematuria, rectal bleeding, unintentional weight loss, persistent cough, hoarseness, dysphagia, persistent headache, a palpable mass. Each is a documented alarm symptom that requires workup before symptomatic treatment. The emergency department is where many of these symptoms surface and where the dismissal pattern often begins; our ER malpractice overview covers the ED-specific anchoring and discharge patterns.
• Abnormal result not followed up. A flagged abnormal lab value or imaging finding that fell into a workflow gap. The result was generated but never communicated to the patient or never tracked to resolution. Office systems failures and EHR workflow failures are documented at the organizational level.
• Missed referral. A finding that warranted specialist referral was handled in primary care or symptomatically rather than referred to oncology, surgical oncology, dermatology, gastroenterology, or pulmonology.
• Missed screening initiation. A patient meeting age or risk criteria for screening (mammography, colonoscopy, low-dose CT for eligible smokers, Pap and HPV, PSA discussion) was not offered or counseled on screening.
• Diagnostic anchoring. The patient was given a diagnosis (anxiety, IBS, COPD exacerbation, fibromyalgia) and subsequent visits were filtered through that anchor without reconsideration even as symptoms changed or escalated.

What we tell every cancer misdiagnosis family: the diagnosis itself is not the question. The question is whether the records show the diagnosis should have been made earlier and whether earlier diagnosis would have changed the trajectory.

Causation: Did the Delay Matter?

Causation is the defendable battlefield in cancer misdiagnosis cases. The defense argues that the delay did not change the outcome because the cancer was aggressive, the patient would have died or progressed regardless, or the actual delay was shorter than plaintiff claims. The plaintiff argues a staging upgrade or a meaningful change in survival probability.

Causation evidence in cancer misdiagnosis cases:

• Stage at the missed diagnosis (counterfactual) vs stage at the actual diagnosis. Reconstructed from imaging, lab markers, growth-rate estimates, and oncology expert testimony.
• Tumor doubling time and growth rate. Estimates from comparison imaging at two time points or from biologically plausible ranges.
• Stage-specific five-year survival data. SEER (Surveillance, Epidemiology, and End Results) program statistics anchored to the relevant histology and stage.
• The treatment regimen received vs the regimen that would have been administered at earlier stage. More aggressive chemotherapy, radiation, or surgery imposed because the cancer was caught late.
• Subsequent disease course. Metastatic disease, recurrence after initial treatment, or death.

Some states recognize a "loss of chance" or "diminished probability of recovery" doctrine that allows recovery even when the patient's survival probability was below 50 percent at the time of the missed diagnosis. In these jurisdictions, a 30 percent reduction in five-year survival can support proportional recovery. Other states require the traditional "more likely than not" causation standard. The state-specific rule shapes the case strategy from the start.

How Cancer Misdiagnosis Cases Are Built

The case is built in the records and the imaging.

• Complete pre-diagnosis medical records. Every primary care visit, every specialist visit, every ER visit, every imaging study, every lab result, every Pap or biopsy in the years before the eventual diagnosis.
• Original imaging. Not the reports, the actual digital files. Plaintiff's radiology expert re-reads.
• Original pathology. The actual slides. Plaintiff's pathology expert re-reads.
• The eventual diagnosis records. Imaging that identified the cancer, biopsy, staging workup, oncology consults, treatment records, response to treatment, recurrence or progression records.
• Patient communication records. Patient portal messages, after-visit summaries, callback logs. Often establishes what the patient was told and not told.
• Office workflow and EHR audit data. Establishes whether abnormal results were reviewed and acknowledged or whether they fell into a gap.

The plaintiff's expert lineup typically includes a board-certified specialist in the area of the missed diagnosis (oncology, radiology, pathology, primary care), a specialist in the relevant cancer's natural history (medical oncology, surgical oncology, radiation oncology), and a damages workup. Most states require a certificate of merit signed by a qualified expert before suit can proceed. For state-by-state filing windows, the same statute of limitations rules that apply to other malpractice cases apply here, often with a discovery rule that starts the clock from when the patient learned of the missed diagnosis. Cancer misdx sits within the broader medical malpractice category of failure-to-diagnose claims; the three-element burden of proof (duty, breach, causation-of-harm) is shared across diagnostic-error contexts.

Damages in Cancer Misdiagnosis Cases

Damages categories:

• Past and future medical expenses. All cancer treatment cost (chemotherapy, radiation, surgery, immunotherapy, supportive care, hospice in fatal cases) and the increment over what would have been required with timely diagnosis. Lifetime surveillance and follow-up for survivors.
• Lost wages and lost earning capacity. Time out of work during treatment and any permanent reduction in earning capacity. Particularly large for working-age patients whose treatment imposed long-term disability.
• Pain and suffering. Subject to state non-economic damage caps in many jurisdictions.
• Loss of consortium. Where state law allows, for spouses of patients with significant impairment or in fatal cases.
• Wrongful death damages. Where the missed diagnosis was fatal. See our wrongful death lawyer overview for state-by-state procedure.
• Survival damages. Pre-death pain and suffering of the decedent in fatal cases.
• Loss of chance damages. In jurisdictions that recognize the doctrine, proportional recovery for the percentage reduction in survival probability caused by the missed diagnosis.